ID   PCCB_HUMAN              Reviewed;         539 AA.
AC   P05166; B7Z2Z4; Q16813; Q96CX0;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Propionyl-CoA carboxylase beta chain, mitochondrial;
DE            Short=PCCase subunit beta;
DE            EC=6.4.1.3;
DE   AltName: Full=Propanoyl-CoA:carbon dioxide ligase subunit beta;
DE   Flags: Precursor;
GN   Name=PCCB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-287.
RC   TISSUE=Fibroblast, Kidney, and Liver;
RX   PubMed=8188292; DOI=10.1006/geno.1994.1099;
RA   Lamhonwah A.-M., Leclerc D., Loyer M., Clarizio R., Gravel R.A.;
RT   "Correction of the metabolic defect in propionic acidemia fibroblasts
RT   by microinjection of a full-length cDNA or RNA transcript encoding the
RT   propionyl-CoA carboxylase beta subunit.";
RL   Genomics 19:500-505(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver, and Placenta;
RX   PubMed=8225321; DOI=10.1007/BF01247343;
RA   Ohura T., Ogasawara M., Ikeda H., Narisawa K., Tada K.;
RT   "The molecular defect in propionic acidemia: exon skipping caused by
RT   an 8-bp deletion from an intron in the PCCB allele.";
RL   Hum. Genet. 92:397-402(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PA-2.
RC   TISSUE=Blood, and Skin fibroblast;
RX   PubMed=9683601; DOI=10.1086/301970;
RA   Rodriguez-Pombo P., Hoenicka J., Muro S., Perez B., Perez-Cerda C.,
RA   Richard E., Desviat L.R., Ugarte M.;
RT   "Human propionyl-CoA carboxylase beta subunit gene: exon-intron
RT   definition and mutation spectrum in Spanish and Latin American
RT   propionic acidemia patients.";
RL   Am. J. Hum. Genet. 63:360-369(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 289-443 (ISOFORM 1).
RX   PubMed=3460076; DOI=10.1073/pnas.83.13.4864;
RA   Lamhonwah A.-M., Barankiewicz T.J., Willard H.F., Mahuran D.J.,
RA   Quan F., Gravel R.A.;
RT   "Isolation of cDNA clones coding for the alpha and beta chains of
RT   human propionyl-CoA carboxylase: chromosomal assignments and DNA
RT   polymorphisms associated with PCCA and PCCB genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:4864-4868(1986).
RN   [9]
RP   PROTEIN SEQUENCE OF 29-33, AND SUBCELLULAR LOCATION.
RC   TISSUE=Kidney;
RX   PubMed=16023992; DOI=10.1016/j.bbrc.2005.06.190;
RA   Stadler S.C., Polanetz R., Meier S., Mayerhofer P.U., Herrmann J.M.,
RA   Anslinger K., Roscher A.A., Roschinger W., Holzinger A.;
RT   "Mitochondrial targeting signals and mature peptides of 3-
RT   methylcrotonyl-CoA carboxylase.";
RL   Biochem. Biophys. Res. Commun. 334:939-946(2005).
RN   [10]
RP   SEQUENCE REVISION.
RA   Lamhonwah A.-M.;
RL   Submitted (DEC-1986) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 401-433, AND VARIANT PA-2 ILE-408
RP   DEL.
RC   TISSUE=Skin fibroblast;
RX   PubMed=2154743; DOI=10.1073/pnas.87.4.1372;
RA   Tahara T., Kraus J.P., Rosenberg L.E.;
RT   "An unusual insertion/deletion in the gene encoding the beta-subunit
RT   of propionyl-CoA carboxylase is a frequent mutation in Caucasian
RT   propionic acidemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:1372-1376(1990).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   VARIANTS PA-2 TRP-410 AND ILE-408 DEL.
RX   PubMed=8411997; DOI=10.1007/BF00710282;
RA   Tahara T., Kraus J.P., Ohura T., Rosenberg L.E., Fenton W.A.;
RT   "Three independent mutations in the same exon of the PCCB gene:
RT   differences between Caucasian and Japanese propionic acidaemia.";
RL   J. Inherit. Metab. Dis. 16:353-360(1993).
RN   [15]
RP   VARIANTS PA-2 MET-17; LYS-168; ASP-205 AND THR-442.
RX   PubMed=10447268;
RX   DOI=10.1002/(SICI)1098-1004(1999)14:1<89::AID-HUMU18>3.3.CO;2-X;
RA   Muro S., Rodriguez-Pombo P., Perez B., Perez-Cerda C., Desviat L.R.,
RA   Sperl W., Skladal D., Sass J.O., Ugarte M.;
RT   "Identification of novel mutations in the PCCB gene in European
RT   propionic acidemia patients.";
RL   Hum. Mutat. 14:89-90(1999).
RN   [16]
RP   REVIEW ON PA VARIANTS.
RX   PubMed=10502773;
RX   DOI=10.1002/(SICI)1098-1004(199910)14:4<275::AID-HUMU1>3.0.CO;2-N;
RA   Ugarte M., Perez-Cerda C., Rodriguez-Pombo P., Desviat L.R., Perez B.,
RA   Richard E., Muro S., Campeau E., Ohura T., Gravel R.A.;
RT   "Overview of mutations in the PCCA and PCCB genes causing propionic
RT   acidemia.";
RL   Hum. Mutat. 14:275-282(1999).
RN   [17]
RP   CHARACTERIZATION OF VARIANTS PA-2 GLN-165; VAL-497; CYS-512; PRO-519
RP   AND ASP-536.
RX   PubMed=11749052; DOI=10.1006/mgme.2001.3254;
RA   Muro S., Perez B., Desviat L.R., Rodriguez-Pombo P., Perez-Cerda C.,
RA   Clavero S., Ugarte M.;
RT   "Effect of PCCB gene mutations on the heteromeric and homomeric
RT   assembly of propionyl-CoA carboxylase.";
RL   Mol. Genet. Metab. 74:476-483(2001).
RN   [18]
RP   VARIANTS PA-2 ILE-428; LEU-430; CYS-435; CYS-439 AND THR-468.
RX   PubMed=12189489; DOI=10.1007/s00439-002-0761-z;
RA   Yorifuji T., Kawai M., Muroi J., Mamada M., Kurokawa K.,
RA   Shigematsu Y., Hirano S., Sakura N., Yoshida I., Kuhara T., Endo F.,
RA   Mitsubuchi H., Nakahata T.;
RT   "Unexpectedly high prevalence of the mild form of propionic acidemia
RT   in Japan: presence of a common mutation and possible clinical
RT   implications.";
RL   Hum. Genet. 111:161-165(2002).
RN   [19]
RP   VARIANTS PA-2 SER-67; MET-107; ASP-112; GLN-165; LYS-168; ARG-188;
RP   VAL-246; ILE-341 DEL AND TRP-410.
RX   PubMed=12559849; DOI=10.1016/S1096-7192(02)00197-X;
RA   Perez B., Desviat L.R., Rodriguez-Pombo P., Clavero S., Navarrete R.,
RA   Perez-Cerda C., Ugarte M.;
RT   "Propionic acidemia: identification of twenty-four novel mutations in
RT   Europe and North America.";
RL   Mol. Genet. Metab. 78:59-67(2003).
RN   [20]
RP   VARIANTS PA-2 PRO-153; TRP-165; TRP-410; ILE-428 AND CYS-512.
RX   PubMed=15059621; DOI=10.1016/j.ymgme.2004.01.003;
RA   Yang X., Sakamoto O., Matsubara Y., Kure S., Suzuki Y., Aoki Y.,
RA   Yamaguchi S., Takahashi Y., Nishikubo T., Kawaguchi C., Yoshioka A.,
RA   Kimura T., Hayasaka K., Kohno Y., Iinuma K., Ohura T.;
RT   "Mutation spectrum of the PCCA and PCCB genes in Japanese patients
RT   with propionic acidemia.";
RL   Mol. Genet. Metab. 81:335-342(2004).
CC   -!- CATALYTIC ACTIVITY: ATP + propanoyl-CoA + HCO(3)(-) = ADP +
CC       phosphate + (S)-methylmalonyl-CoA.
CC   -!- PATHWAY: Metabolic intermediate metabolism; propanoyl-CoA
CC       degradation; succinyl-CoA from propanoyl-CoA: step 1/3.
CC   -!- SUBUNIT: Probably a dodecamer composed of six biotin-containing
CC       alpha subunits and six beta subunits.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:16023992}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05166-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05166-2; Sequence=VSP_042568;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Propionic acidemia type II (PA-2) [MIM:606054]: Life-
CC       threatening disease characterized by episodic vomiting, lethargy
CC       and ketosis, neutropenia, periodic thrombocytopenia,
CC       hypogammaglobulinemia, developmental retardation, and intolerance
CC       to protein. {ECO:0000269|PubMed:10447268,
CC       ECO:0000269|PubMed:11749052, ECO:0000269|PubMed:12189489,
CC       ECO:0000269|PubMed:12559849, ECO:0000269|PubMed:15059621,
CC       ECO:0000269|PubMed:2154743, ECO:0000269|PubMed:8411997,
CC       ECO:0000269|PubMed:9683601}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the AccD/PCCB family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X73424; CAA51825.1; -; mRNA.
DR   EMBL; S67325; AAB28900.1; -; mRNA.
DR   EMBL; AJ006487; CAA07066.1; -; Genomic_DNA.
DR   EMBL; AJ006488; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006489; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006490; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006491; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006492; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006493; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006494; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006495; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006496; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006497; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006498; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AJ006499; CAA07066.1; JOINED; Genomic_DNA.
DR   EMBL; AK295312; BAH12030.1; -; mRNA.
DR   EMBL; AC069524; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79118.1; -; Genomic_DNA.
DR   EMBL; BC013768; AAH13768.1; -; mRNA.
DR   EMBL; BC053661; AAH53661.1; -; mRNA.
DR   EMBL; M13573; AAA60036.1; -; mRNA.
DR   EMBL; M31167; AAA60037.1; -; Genomic_DNA.
DR   EMBL; M31169; AAA60038.1; -; Genomic_DNA.
DR   CCDS; CCDS3089.1; -. [P05166-1]
DR   CCDS; CCDS54643.1; -. [P05166-2]
DR   PIR; T45009; T45009.
DR   RefSeq; NP_000523.2; NM_000532.4. [P05166-1]
DR   RefSeq; NP_001171485.1; NM_001178014.1. [P05166-2]
DR   UniGene; Hs.63788; -.
DR   ProteinModelPortal; P05166; -.
DR   SMR; P05166; -.
DR   BioGrid; 111129; 14.
DR   DIP; DIP-38244N; -.
DR   IntAct; P05166; 10.
DR   MINT; MINT-3004663; -.
DR   STRING; 9606.ENSP00000419027; -.
DR   DrugBank; DB00121; Biotin.
DR   DrugBank; DB00161; L-Valine.
DR   iPTMnet; P05166; -.
DR   PhosphoSitePlus; P05166; -.
DR   BioMuta; PCCB; -.
DR   DMDM; 124106304; -.
DR   EPD; P05166; -.
DR   MaxQB; P05166; -.
DR   PaxDb; P05166; -.
DR   PeptideAtlas; P05166; -.
DR   PRIDE; P05166; -.
DR   DNASU; 5096; -.
DR   Ensembl; ENST00000251654; ENSP00000251654; ENSG00000114054. [P05166-1]
DR   Ensembl; ENST00000469217; ENSP00000419027; ENSG00000114054. [P05166-2]
DR   GeneID; 5096; -.
DR   KEGG; hsa:5096; -.
DR   UCSC; uc003eqy.3; human. [P05166-1]
DR   CTD; 5096; -.
DR   DisGeNET; 5096; -.
DR   GeneCards; PCCB; -.
DR   GeneReviews; PCCB; -.
DR   HGNC; HGNC:8654; PCCB.
DR   HPA; HPA036939; -.
DR   HPA; HPA036940; -.
DR   MalaCards; PCCB; -.
DR   MIM; 232050; gene.
DR   MIM; 606054; phenotype.
DR   neXtProt; NX_P05166; -.
DR   OpenTargets; ENSG00000114054; -.
DR   Orphanet; 35; Propionic acidemia.
DR   PharmGKB; PA32993; -.
DR   eggNOG; KOG0540; Eukaryota.
DR   eggNOG; COG4799; LUCA.
DR   GeneTree; ENSGT00530000063337; -.
DR   HOGENOM; HOG000218693; -.
DR   HOVERGEN; HBG003970; -.
DR   InParanoid; P05166; -.
DR   KO; K01966; -.
DR   PhylomeDB; P05166; -.
DR   TreeFam; TF314350; -.
DR   BioCyc; MetaCyc:ENSG00000114054-MONOMER; -.
DR   Reactome; R-HSA-196780; Biotin transport and metabolism.
DR   Reactome; R-HSA-3371599; Defective HLCS causes multiple carboxylase deficiency.
DR   Reactome; R-HSA-71032; Propionyl-CoA catabolism.
DR   SABIO-RK; P05166; -.
DR   UniPathway; UPA00945; UER00908.
DR   ChiTaRS; PCCB; human.
DR   GenomeRNAi; 5096; -.
DR   PRO; PR:P05166; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114054; -.
DR   CleanEx; HS_PCCB; -.
DR   ExpressionAtlas; P05166; baseline and differential.
DR   Genevisible; P05166; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004658; F:propionyl-CoA carboxylase activity; TAS:ProtInc.
DR   GO; GO:0006768; P:biotin metabolic process; TAS:Reactome.
DR   GO; GO:0019626; P:short-chain fatty acid catabolic process; TAS:Reactome.
DR   InterPro; IPR034733; AcCoA_carboxyl.
DR   InterPro; IPR029045; ClpP/crotonase-like_dom.
DR   InterPro; IPR011763; COA_CT_C.
DR   InterPro; IPR011762; COA_CT_N.
DR   Pfam; PF01039; Carboxyl_trans; 1.
DR   SUPFAM; SSF52096; SSF52096; 2.
DR   PROSITE; PS50989; COA_CT_CTER; 1.
DR   PROSITE; PS50980; COA_CT_NTER; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Ligase; Mitochondrion;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     28       Mitochondrion.
FT                                {ECO:0000269|PubMed:16023992}.
FT   CHAIN        29    539       Propionyl-CoA carboxylase beta chain,
FT                                mitochondrial.
FT                                /FTId=PRO_0000000293.
FT   DOMAIN       32    290       CoA carboxyltransferase N-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01136}.
FT   DOMAIN      294    533       CoA carboxyltransferase C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01137}.
FT   REGION       32    533       Carboxyltransferase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01138}.
FT   REGION      325    358       Acyl-CoA binding. {ECO:0000255}.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      99     99       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99MN9}.
FT   MOD_RES      99     99       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99MN9}.
FT   MOD_RES     248    248       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99MN9}.
FT   MOD_RES     474    474       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99MN9}.
FT   MOD_RES     474    474       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99MN9}.
FT   MOD_RES     489    489       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99MN9}.
FT   MOD_RES     489    489       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99MN9}.
FT   VAR_SEQ     124    124       Q -> QQIIGWAQWLPLVISALWEAE (in isoform
FT                                2). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042568.
FT   VARIANT      17     17       L -> M (in PA-2; dbSNP:rs200185747).
FT                                {ECO:0000269|PubMed:10447268}.
FT                                /FTId=VAR_009080.
FT   VARIANT      44     44       R -> P (in PA-2).
FT                                /FTId=VAR_000271.
FT   VARIANT      67     67       R -> S (in PA-2; dbSNP:rs747053913).
FT                                {ECO:0000269|PubMed:12559849}.
FT                                /FTId=VAR_023847.
FT   VARIANT     106    106       S -> R (in PA-2).
FT                                /FTId=VAR_000272.
FT   VARIANT     107    107       V -> M (in PA-2).
FT                                {ECO:0000269|PubMed:12559849}.
FT                                /FTId=VAR_023848.
FT   VARIANT     112    112       G -> D (in PA-2; dbSNP:rs202247818).
FT                                {ECO:0000269|PubMed:12559849}.
FT                                /FTId=VAR_023849.
FT   VARIANT     131    131       G -> R (in PA-2).
FT                                /FTId=VAR_000273.
FT   VARIANT     140    140       K -> KICK (in PA-2).
FT                                /FTId=VAR_009081.
FT   VARIANT     153    153       A -> P (in PA-2; dbSNP:rs202247819).
FT                                {ECO:0000269|PubMed:15059621}.
FT                                /FTId=VAR_023850.
FT   VARIANT     165    165       R -> Q (in PA-2; does not affect either
FT                                heteromeric or homomeric assembly).
FT                                {ECO:0000269|PubMed:11749052,
FT                                ECO:0000269|PubMed:12559849}.
FT                                /FTId=VAR_023851.
FT   VARIANT     165    165       R -> W (in PA-2).
FT                                {ECO:0000269|PubMed:15059621}.
FT                                /FTId=VAR_000274.
FT   VARIANT     168    168       E -> K (in PA-2; common mutation;
FT                                dbSNP:rs121964960).
FT                                {ECO:0000269|PubMed:10447268,
FT                                ECO:0000269|PubMed:12559849}.
FT                                /FTId=VAR_000275.
FT   VARIANT     188    188       G -> R (in PA-2; dbSNP:rs746102997).
FT                                {ECO:0000269|PubMed:12559849}.
FT                                /FTId=VAR_023852.
FT   VARIANT     198    198       G -> D (in PA-2; dbSNP:rs762354873).
FT                                /FTId=VAR_000276.
FT   VARIANT     205    205       V -> D (in PA-2).
FT                                {ECO:0000269|PubMed:10447268}.
FT                                /FTId=VAR_009082.
FT   VARIANT     228    228       P -> L (in PA-2; dbSNP:rs374722096).
FT                                /FTId=VAR_009083.
FT   VARIANT     246    246       G -> V (in PA-2).
FT                                {ECO:0000269|PubMed:12559849}.
FT                                /FTId=VAR_023853.
FT   VARIANT     287    287       P -> S (in dbSNP:rs2228310).
FT                                {ECO:0000269|PubMed:8188292}.
FT                                /FTId=VAR_048163.
FT   VARIANT     341    341       Missing (in PA-2).
FT                                {ECO:0000269|PubMed:12559849}.
FT                                /FTId=VAR_023854.
FT   VARIANT     408    408       Missing (in PA-2).
FT                                {ECO:0000269|PubMed:2154743,
FT                                ECO:0000269|PubMed:8411997}.
FT                                /FTId=VAR_000277.
FT   VARIANT     410    410       R -> W (in PA-2; dbSNP:rs121964959).
FT                                {ECO:0000269|PubMed:12559849,
FT                                ECO:0000269|PubMed:15059621,
FT                                ECO:0000269|PubMed:8411997}.
FT                                /FTId=VAR_000278.
FT   VARIANT     428    428       T -> I (in PA-2; dbSNP:rs28934887).
FT                                {ECO:0000269|PubMed:12189489,
FT                                ECO:0000269|PubMed:15059621}.
FT                                /FTId=VAR_009084.
FT   VARIANT     430    430       I -> L (in PA-2).
FT                                {ECO:0000269|PubMed:12189489}.
FT                                /FTId=VAR_023855.
FT   VARIANT     435    435       Y -> C (in PA-2; dbSNP:rs121964961).
FT                                {ECO:0000269|PubMed:12189489}.
FT                                /FTId=VAR_023856.
FT   VARIANT     439    439       Y -> C (in PA-2; dbSNP:rs769521436).
FT                                {ECO:0000269|PubMed:12189489}.
FT                                /FTId=VAR_023857.
FT   VARIANT     442    442       M -> T (in PA-2).
FT                                {ECO:0000269|PubMed:10447268}.
FT                                /FTId=VAR_009085.
FT   VARIANT     468    468       A -> T (in PA-2; dbSNP:rs775563122).
FT                                {ECO:0000269|PubMed:12189489}.
FT                                /FTId=VAR_023858.
FT   VARIANT     497    497       A -> V (in PA-2; common mutation; does
FT                                not affect either heteromeric or
FT                                homomeric assembly; dbSNP:rs142403318).
FT                                {ECO:0000269|PubMed:11749052}.
FT                                /FTId=VAR_000279.
FT   VARIANT     512    512       R -> C (in PA-2; affects heteromeric and
FT                                homomeric assembly; dbSNP:rs186710233).
FT                                {ECO:0000269|PubMed:11749052,
FT                                ECO:0000269|PubMed:15059621}.
FT                                /FTId=VAR_000280.
FT   VARIANT     519    519       L -> P (in PA-2; affects heteromeric and
FT                                homomeric assembly; dbSNP:rs202247822).
FT                                {ECO:0000269|PubMed:11749052}.
FT                                /FTId=VAR_000281.
FT   VARIANT     536    536       N -> D (in PA-2; affects heteromeric and
FT                                homomeric assembly; dbSNP:rs202247823).
FT                                {ECO:0000269|PubMed:11749052}.
FT                                /FTId=VAR_009086.
FT   CONFLICT     58     59       QH -> HD (in Ref. 2; AAB28900).
FT                                {ECO:0000305}.
SQ   SEQUENCE   539 AA;  58216 MW;  A2DAAC00312D3C0F CRC64;
     MAAALRVAAV GARLSVLASG LRAAVRSLCS QATSVNERIE NKRRTALLGG GQRRIDAQHK
     RGKLTARERI SLLLDPGSFV ESDMFVEHRC ADFGMAADKN KFPGDSVVTG RGRINGRLVY
     VFSQDFTVFG GSLSGAHAQK ICKIMDQAIT VGAPVIGLND SGGARIQEGV ESLAGYADIF
     LRNVTASGVI PQISLIMGPC AGGAVYSPAL TDFTFMVKDT SYLFITGPDV VKSVTNEDVT
     QEELGGAKTH TTMSGVAHRA FENDVDALCN LRDFFNYLPL SSQDPAPVRE CHDPSDRLVP
     ELDTIVPLES TKAYNMVDII HSVVDEREFF EIMPNYAKNI IVGFARMNGR TVGIVGNQPK
     VASGCLDINS SVKGARFVRF CDAFNIPLIT FVDVPGFLPG TAQEYGGIIR HGAKLLYAFA
     EATVPKVTVI TRKAYGGAYD VMSSKHLCGD TNYAWPTAEI AVMGAKGAVE IIFKGHENVE
     AAQAEYIEKF ANPFPAAVRG FVDDIIQPSS TRARICCDLD VLASKKVQRP WRKHANIPL
//
